Molecular cytogenetic characterization of a case of Müllerian adenosarcoma

Cancer Genetics and Cytogenetics

Volumn 148, Issue 2, 2004, Pages 129-132

  Chen, Zhong ^a   Hong, Bo ^a   Drozd Borysiuk, Elizabeth ^a   Coffin, Cheryl ^a   Albritton, Karen ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADOLESCENT; ARTICLE; CANCER SURGERY; CASE REPORT; CHROMOSOME 10; CHROMOSOME 13; CHROMOSOME 19; CHROMOSOME 2; CHROMOSOME 21; CHROMOSOME 8; CHROMOSOME ANALYSIS; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; FEMALE; GENETIC ANALYSIS; HUMAN; KARYOTYPE; MUELLERIAN DUCT; MULLERIAN ADENOCARCINOMA; PRIORITY JOURNAL;

EID: 0347721045     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(03)00212-7     Document Type: Article

References (18)

1. Clement P.B., Scully R.E. Müllerian adenosarcoma of the uterus. A clinicopathologic analysis of ten cases of a distinctive type of mullerian mixed tumor. Cancer. 34:1974;1138-1149.
2. Clement P.B., Scully R.E. Extrauterine mesodermal (Müllerian) adenosarcoma: a clinicopathologic analysis of five cases. Am J Clin Pathol. 69:1978;276-283.
3. Clement P.B. Müllerian adenosarcomas of the uterus with sarcomatous overgrowth. A clinicopathological analysis of 10 cases. Am J Surg Pathol. 13:1989;28-38.
4. Ostor A.G., Nirenberg A., Ashdown M.L., Murphy D.J. Extragenital adenosarcoma arising in the pouch of Douglas. Gynecol Oncol. 53:1994;373-375.
5. Chen Z., Coffin C.M., Scott S., Meloni-Ehrig A., Shepard R., Issa B., Forsyth D.R., Sandberg A.A., Brothman A.R., Lowichik A. Evidence by spectral karyotyping that 8q11.2 is nonrandomly involved in lipoblastoma. J Mol Diag. 2:2000;73-77.
6. Mitelman F. An international system for human cytogenetic nomenclature. 1995;S. Karger, Basel.
7. Clement P.B., Scully R.E. Müllerian adenosarcoma of the uterus: a clinicopathologic analysis of 100 cases with a review of the literature. Hum Pathol. 21:1990;363.
8. Andrade L.A., Derchain S.F.M., Vial J.S., Alvarenga M. Müllerian adenosarcoma of the uterus in adolescents. Int J Gynecol Obstet. 38:1992;119-123.
9. Kato N., Zhe J., Endoh Y., Motoyama T. Extrauterine Müllerian adenosarcoma of the peritoneum with an extensive rhabdomyosarcomatous element and a marked myxoid change. Pathol Int. 50:2000;347-351.
10. Norris H.J., Zaloudek C.Y. Mesenchymal tumors of the uterus. Kurman R.J. Blaustein's pathology of the female genital tract. 1987;342-392 Springer-Verlag, New York.
11. Sreekantaiah C., Rao U.N.M., Sandberg A.A. Complex karyotypic aberrations, including i(12p), in malignant mixed Müllerian tumor of uterus. Cancer Genet Cytogenet. 60:1992;78-81.
12. Laxman R., Currie J.L., Kurman R.J., Dudzinski M., Griffin C.A. Cytogenetic profile of uterine sarcomas. Cancer. 71:1992;1283-1288.
13. Atkin N.B., Baker M.C. Abnormal chromosomes including small metacentrics in 14 ovarian cancers. Cancer Genet Cytogenet. 26:1987;355-361.
14. Pejovic T., Heim S., Mandahl N., Floderus U.-M., Willen H., Mitelman F. Complex karyotypic anomalies, including an i(5p) marker chromosome, in malignant mixed mesodermal tumor of the ovary. Cancer Genet Cytogenet. 46:1990;65-69.
15. Fletcher J.A., Kozakewich H.P., Hoffer F.A., Lage J.M., Weidner N., Tepper R., Pinkus G.S., Morton C.C., Corson J.M. Diagnostic relevance of clonal cytogenetic aberrations in malignant soft-tissue tumors. N Engl J Med. 324:1991;436-442.
16. Pejovic T., Alan P., Iosif S.C., Mitelman F., Heim S. Cytogenetic findings in four malignant mixed mesodermal tumors of the ovary. Cancer Genet Cytogenet. 88:1996;53-56.
17. Sreekantaiah C., Kwark E., Chuang L.T., Ladanyi M. Cytogenetic and molecular characterization of a malignant mixed Müllerian tumor of the uterus with a t(8;22)(q24.1;q12). Cancer Genet Cytogenet. 115:1999;73-76.
18. Kitagawa K., Murata A., Matsuura N., Tohya K., Takaichi S., Monden M., Inoue M. Epithelial-mesenchymal transformation of a newly established cell line from ovarian adenosarcoma by transforming growth factor-β1. Int J Cancer. 66:1996;91-97.